Conversion TORS after neoadjuvant immunotherapy for advanced BOT-SCC: a retrospective study.

Front Oncol · 2025 · PMC12815781 · PMID 41568389

Europe PMC DOI

hedged sentences

0.0620

closest p · 1.2× alpha

0.1780

boldest claim

The sentences

showed a trendp = 0.062so close (0.05 < p ≤ 0.1)

HPV-positive cases also showed a trend toward shorter operative times (167.0 ± 34.2 min vs . 226.3 ± 40.0 min; 95% CI: −2.95 to 0.08; p = 0.062) and reduced blood loss (64.0 ± 9.3 mL vs . 96.3 ± 29.7 mL; 95% CI: −2.89 to 0.11; p = 0.106) compared to HPV-negative cases ( Table 7 ). 3.6.

also in 53,322 other papers

did not reach statistical significancep = 0.178not close (p > 0.1)

Operative time was shorter in the PR group, although the difference did not reach statistical significance (176.7 ± 33.1 min vs . 225.0 ± 49.3 min; 95% CI: −2.62 to 0.39; p = 0.178).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.